canada semaglutide patent Ozempic among 'bogus' drug patents being challenged by U.S. to spur competition novo nordisk semaglutide patent fee

Unlike single-pathway peptides, retatrutide aims to control multiple metabolic triggers at once, creating more sustainable shifts in hunger, cravings, nutrient use, and basal metabolic rate

Those that were reported were generally mild and severe adverse events were rare

GLP-1 users must exercise If your client is on a GLP-1, wouldnt you want to do everything possible to leverage its effectiveness and help them lose the most weight while on it

Generally, healthcare professionals recommend increased exercise and a lower-calorie diet, but prescription medications may be recommended if sufficient weight loss is not achieved after six months

Ren, C., Zhang, H., Wu, T

Mazdutide availability Mazdutide received approval in China in June 2025, marketed under the brand name Xinermei by Innovent Biologics